2026年3月5日,Teva内幕人士出售了130多万美元的股票,因为该公司报告收入丰厚,提高了2026年的预测。 On March 5, 2026, Teva insiders sold over $1.3 million in stock as the company reported strong earnings and raised its 2026 forecast.

2026年3月5日, Teva制药工业公司多位内幕人士出售股票, 包括一位执行副总裁、另一位内幕人士和Eric Hughes, On March 5, 2026, multiple insiders at Teva Pharmaceutical Industries sold shares, including an executive vice president, another insider, and Eric Hughes, collectively reducing their stakes by significant percentages. 这些交易在证交会申报中披露,总额超过130万美元。 The transactions, disclosed in SEC filings, totaled over $1.3 million. Teva的股票于3月9日上涨至31.44美元, Teva’s stock rose to $31.44 on March 9, with elevated trading volume, following strong Q4 earnings and an upgraded 2026 earnings forecast. 该公司报告的EPS为0.96美元,超过估计值,收入逐年增长11.4%。 The company reported $0.96 EPS, exceeding estimates, and revenue up 11.4% year-over-year. 分析师维持“机动购买”共识,目标是37.67美元。 Analysts maintain a “Moderate Buy” consensus with a target of $37.67.